| Dylan Kramarich, | |
|
2600 Sixth St Sw, Canton, OH 44710-1702 | |
| (330) 363-7462 | |
| Not Available |
| Full Name | Dylan Kramarich |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 2600 Sixth St Sw, Canton, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033883681 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN.424273 (Ohio) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | APRN.CRNA.0020393 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aultman Hospital | Canton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aultman Deuble Heart And Vascular Hospital, Llc | 1850726126 | 87 |
| Ohio Hospital-based Physicians Corporation | 9133019110 | 65 |
News Archive
What if our immune system could cure cancer? This logic seems almost too simple to be true, but it forms the basis of an emerging cancer treatment—immunotherapy.
Researchers in the UK have presented a multi-omics integrated blood atlas that delineates the host immune response in patients with coronavirus disease 2019 (COVID-19) of varying severity, providing a unique reference resource for the interpretation of datasets generated from interventional trials.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that the paper "An alpha-2C-Adrenergic Receptor Polymorphism Alters the Norepinephrine Lowering Effects and Therapeutic Response of the Beta Blocker Bucindolol in Chronic Heart Failure" was published in the January 2010 edition of the peer-reviewed journal Circulation: Heart Failure (http://circheartfailure.ahajournals.org).
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced today that it was awarded $843,289 in funding from the National Institutes of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to support the development of human monoclonal antibody (mAb) therapies against staphylococcal-derived toxin(s).
For the second time, The Leapfrog Group has named UC San Diego Health System to its annual list of Top Hospitals. Awarded to hospitals nationwide for demonstrating excellence in hospital safety and quality, the Leapfrog Top Hospital award is an elite distinction given to less than seven percent of all eligible hospitals. The awards were announced on December 2, in Washington, D.C.
› Verified 6 days ago
| Entity Name | Ohio Hospital-based Physicians Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891727079 PECOS PAC ID: 9133019110 Enrollment ID: O20040316000515 |
News Archive
What if our immune system could cure cancer? This logic seems almost too simple to be true, but it forms the basis of an emerging cancer treatment—immunotherapy.
Researchers in the UK have presented a multi-omics integrated blood atlas that delineates the host immune response in patients with coronavirus disease 2019 (COVID-19) of varying severity, providing a unique reference resource for the interpretation of datasets generated from interventional trials.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that the paper "An alpha-2C-Adrenergic Receptor Polymorphism Alters the Norepinephrine Lowering Effects and Therapeutic Response of the Beta Blocker Bucindolol in Chronic Heart Failure" was published in the January 2010 edition of the peer-reviewed journal Circulation: Heart Failure (http://circheartfailure.ahajournals.org).
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced today that it was awarded $843,289 in funding from the National Institutes of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to support the development of human monoclonal antibody (mAb) therapies against staphylococcal-derived toxin(s).
For the second time, The Leapfrog Group has named UC San Diego Health System to its annual list of Top Hospitals. Awarded to hospitals nationwide for demonstrating excellence in hospital safety and quality, the Leapfrog Top Hospital award is an elite distinction given to less than seven percent of all eligible hospitals. The awards were announced on December 2, in Washington, D.C.
› Verified 6 days ago
| Entity Name | Aultman Deuble Heart & Vascular Hospital, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306495718 PECOS PAC ID: 1850726126 Enrollment ID: O20200114002347 |
News Archive
What if our immune system could cure cancer? This logic seems almost too simple to be true, but it forms the basis of an emerging cancer treatment—immunotherapy.
Researchers in the UK have presented a multi-omics integrated blood atlas that delineates the host immune response in patients with coronavirus disease 2019 (COVID-19) of varying severity, providing a unique reference resource for the interpretation of datasets generated from interventional trials.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that the paper "An alpha-2C-Adrenergic Receptor Polymorphism Alters the Norepinephrine Lowering Effects and Therapeutic Response of the Beta Blocker Bucindolol in Chronic Heart Failure" was published in the January 2010 edition of the peer-reviewed journal Circulation: Heart Failure (http://circheartfailure.ahajournals.org).
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced today that it was awarded $843,289 in funding from the National Institutes of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to support the development of human monoclonal antibody (mAb) therapies against staphylococcal-derived toxin(s).
For the second time, The Leapfrog Group has named UC San Diego Health System to its annual list of Top Hospitals. Awarded to hospitals nationwide for demonstrating excellence in hospital safety and quality, the Leapfrog Top Hospital award is an elite distinction given to less than seven percent of all eligible hospitals. The awards were announced on December 2, in Washington, D.C.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dylan Kramarich, Po Box 80690, Canton, OH 44708-0690 Ph: (330) 363-7444 | Dylan Kramarich, 2600 Sixth St Sw, Canton, OH 44710-1702 Ph: (330) 363-7462 |
News Archive
What if our immune system could cure cancer? This logic seems almost too simple to be true, but it forms the basis of an emerging cancer treatment—immunotherapy.
Researchers in the UK have presented a multi-omics integrated blood atlas that delineates the host immune response in patients with coronavirus disease 2019 (COVID-19) of varying severity, providing a unique reference resource for the interpretation of datasets generated from interventional trials.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that the paper "An alpha-2C-Adrenergic Receptor Polymorphism Alters the Norepinephrine Lowering Effects and Therapeutic Response of the Beta Blocker Bucindolol in Chronic Heart Failure" was published in the January 2010 edition of the peer-reviewed journal Circulation: Heart Failure (http://circheartfailure.ahajournals.org).
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced today that it was awarded $843,289 in funding from the National Institutes of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to support the development of human monoclonal antibody (mAb) therapies against staphylococcal-derived toxin(s).
For the second time, The Leapfrog Group has named UC San Diego Health System to its annual list of Top Hospitals. Awarded to hospitals nationwide for demonstrating excellence in hospital safety and quality, the Leapfrog Top Hospital award is an elite distinction given to less than seven percent of all eligible hospitals. The awards were announced on December 2, in Washington, D.C.
› Verified 6 days ago
Sarah Gomez, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4665 Douglas Cir Nw, Canton, OH 44718 Phone: 330-499-5700 | |
Roxie Lee Rush, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2600 Sixth Street Sw, Ohio Hospital Based Physician Corp, Canton, OH 44710 Phone: 330-363-7462 Fax: 330-363-7679 | |
Mr. Kevin White, C.R.N.A. Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2600 Sixth St Sw, Canton, OH 44710 Phone: 330-363-7462 Fax: 330-363-7679 | |
Amanda G Gillis, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4665 Douglas Cir Nw, #100, Canton, OH 44718 Phone: 330-499-5700 Fax: 330-498-4229 | |
Arlene Ann Weeber, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2600 6th St Sw, Ohio Hospital Based Physician Corp, Canton, OH 44710 Phone: 330-363-7462 Fax: 330-363-7679 | |
Sheree Boyle, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2600 Sixth St Sw, Canton, OH 44710 Phone: 330-363-7462 Fax: 330-363-7679 | |
Lois R Milosevic, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1320 Mercy Dr Nw, Canton, OH 44708 Phone: 330-489-1111 |